Ethyl 4-hydroxypyrazolo[1,5-a]pyridine-3-carboxylate, 98%, 250mg

N-(1H-1,2,3-Benzotriazol-1-ylmethyl)-N-(4-methoxyphenyl)acetamide, 100mg

Benzenemethanol, 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 95%, 100mg

6-Phenylpyridine-2-carboxylic Acid>98.0%(GC)(T)5g

Colonna capillare per GC ROTI®Cap-1701, 50 m, 0.53 mm, 2.00 µm, 1 Pezzo(i)

5-Bromo-2-chloro-4-fluorobenzaldehyde, 97%, 1g

TERT-BUTYL 2-(5-CHLOROBENZO[D]OXAZOL-2-YLAMINO)ETHYLCARBAMATE, 95.0%, 1g

2-((tert-Butoxycarbonyl)amino)ethyl 4-methylbenzenesulfonate, 95.0%, 10g

2-Chloro-4-methyl-7-aminoquinoline, 97.0%, 1g

7-Methoxy-2-phenyl-4H-chromen-4-one, 95.0%, 1g

4-(Methoxymethyl)-1-piperidinesulfonyl chloride, 95.0%, 250mg

4'-methyl-2-pyrrolidinomethyl benzophenone, 97.0%, 1g

Decane-1,10-diamine, 95.0%, 1kg